Biomarkers for assessing occupational exposures to 1,3-butadiene

被引:61
|
作者
Albertini, RJ
Sram, RJ
Vacek, PM
Lynch, J
Wright, M
Nicklas, JA
Boogaard, PJ
Henderson, RF
Swenberg, JA
Tates, AD
Ward, JB
机构
[1] Univ Vermont, Genet Toxicol Lab, Burlington, VT 05401 USA
[2] Lab Genet Ecotoxicol, Prague, Czech Republic
[3] Shell Internat Chem BV, Amsterdam, Netherlands
[4] Lovelace Resp Res Inst, Albuquerque, NM USA
[5] Univ N Carolina, Chapel Hill, NC USA
[6] Leiden Univ, Leiden, Netherlands
[7] Univ Texas, Med Branch, Galveston, TX 77550 USA
[8] Hlth & Safety Lab, Sheffield, S Yorkshire, England
关键词
D O I
10.1016/S0009-2797(01)00181-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The overall objective of this study was to evaluate a continuum of biomarkers in blood and urine for their sensitivities as indicators of low level occupational exposures to 1,3 butadiene (BD). The study design was largely cross-sectional, with biological samples collected within a short timeframe. Personal 8-h BD exposure measures were made on several occasions over a 60-day period for each potentially exposed worker in order provide maximum accuracy for this independent variable and to accommodate the different expression intervals of the several biomarkers. Co-exposures to styrene, toluene and benzene were also measured. The study included 24 BD monomer production workers (mean BD exposure =0.642 mg/m(3)), 34 polymerization workers (mean BD exposure =1.794 mg/ml) and 25 controls (mean BD exposure =0.023 mg/m(3)). The several biomarkers were measured by a consortium of investigators at different locations in the US and Europe. These biomarkers included: (1) metabolic genotypes (CYP2E1. EH, GST M1, GST T1, ADH2, ADH3), determined in Prague and Burlington. VT; (2) urinary M1 and M2 metabolites (1,2-dihydroxy-4-[N-acetylcysteinyl]-butane and 1-hydroxy-2-[N-acetyleysteinyl]-3-butene, respectively), determined in Albuquerque, NM and Leiden; (3) hemoglobin adducts (N-[2-dihydroxy-3-butenyl]valine = HBVal and N-[2,3,4-trihydroxybutyl]valine = THBVal), determined in Amsterdam and Chapel Hill, NC, respectively; (4) HPRT mutations determined by autoradiographic assay in Galveston, TX, with slides re-read in Burlington, VT; (6) hypoxanthine-guanine phosphoribosyltransferase (HPRT) mutations determined by cloning assay in Leiden with mutational spectra characterized in Burlington, VT; (7) sister chromatid exchanges and chromosome aberrations determined by standard methods and FISH analysis in Prague. Urinary M1 and M2 metabolites and HBVal and THBVal hemoglobin adducts were all significantly correlated with BD exposure levels, with adducts being the most highly associated. No significant relationships were observed between BD exposures and HPRT mutations or any of the cytogenetic endpoints, regardless of method of assay. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:429 / 453
页数:25
相关论文
共 50 条
  • [1] Haemoglobin adducts as biomarkers of occupational exposure to 1,3-butadiene
    OstermanGolkar, S
    Peltonen, K
    AnttinenKlemetti, T
    Landin, HH
    Zorcec, V
    Sorsa, M
    MUTAGENESIS, 1996, 11 (02) : 145 - 149
  • [2] CARCINOGENICITY OF EXPOSURES TO 1,3-BUTADIENE
    VAINO, H
    HESELTINE, E
    WILBOURN, J
    SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 1992, 18 (05) : 330 - 332
  • [3] OCCUPATIONAL EXPOSURE TO 1,3-BUTADIENE
    DAVIS, DL
    LANCET, 1987, 1 (8528): : 326 - 326
  • [4] OCCUPATIONAL EXPOSURE OF WORKERS TO 1,3-BUTADIENE
    FAJEN, JM
    ROBERTS, DR
    UNGERS, LJ
    KRISHNAN, ER
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1990, 86 : 11 - 18
  • [5] An updated lymphohematopoietic and bladder cancers risk evaluation for occupational and environmental exposures to 1,3-butadiene
    Valdez-Flores, C.
    Erraguntla, N.
    Budinsky, R.
    Cagen, S.
    Kirman, C. R.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 366
  • [6] 1,3-Butadiene: Biomarkers and application to risk assessment
    Swenberg, James A.
    Bordeerat, Narisa K.
    Boysen, Gunnar
    Carro, Sujey
    Georgieva, Nadia I.
    Nakamura, Jun
    Troutman, John M.
    Upton, Patricia B.
    Albertini, Richard J.
    Vacek, Pamela M.
    Walker, Vernon E.
    Sram, Radim J.
    Goggin, Melissa
    Tretyakova, Natalia
    CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 192 (1-2) : 150 - 154
  • [7] 1,3-Butadiene
    Luttrell, William E.
    Sizemore, Caroline E.
    JOURNAL OF CHEMICAL HEALTH & SAFETY, 2013, 20 (03): : 54 - 56
  • [8] HUMAN CYTOGENETIC BIOMONITORING OF OCCUPATIONAL EXPOSURE TO 1,3-BUTADIENE
    SORSA, M
    AUTIO, K
    DEMOPOULOS, NA
    JARVENTAUS, H
    ROSSNER, P
    SRAM, RJ
    STEPHANOU, G
    VLACHODIMITROPOULOS, D
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1994, 309 (02) : 321 - 326
  • [9] Appraisal of levels and patterns of occupational exposure to 1,3-butadiene
    Scarselli, Alberto
    Corfiati, Marisa
    Di Marzio, Davide
    Iavicoli, Sergio
    SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 2017, 43 (05) : 494 - 503
  • [10] 2.5 PPM 1,3-BUTADIENE OR 0.07 PPM 1,3-BUTADIENE
    GALLO, F
    WROBLEWSKI, SC
    HINTON, JJ
    HARRIS, LC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 38 - CHAS